Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

BACKGROUND: The morbidity and socioeconomic effects of onchocerciasis, a parasitic disease that is primarily endemic in sub-Saharan Africa, have motivated large morbidity and transmission control programmes. Annual community-directed ivermectin treatment has substantially reduced prevalence. Elimina...

Descripción completa

Detalles Bibliográficos
Autores principales: Opoku, Nicholas O, Bakajika, Didier K, Kanza, Eric M, Howard, Hayford, Mambandu, Germain L, Nyathirombo, Amos, Nigo, Maurice M, Kasonia, Kambale, Masembe, Safari L, Mumbere, Mupenzi, Kataliko, Kambale, Larbelee, Jemmah P, Kpawor, Mawolo, Bolay, Kpehe M, Bolay, Fatorma, Asare, Sampson, Attah, Simon K, Olipoh, George, Vaillant, Michel, Halleux, Christine M, Kuesel, Annette C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172290/
https://www.ncbi.nlm.nih.gov/pubmed/29361335
http://dx.doi.org/10.1016/S0140-6736(17)32844-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172290/
https://www.ncbi.nlm.nih.gov/pubmed/29361335
http://dx.doi.org/10.1016/S0140-6736(17)32844-1

Ejemplares similares